Home > News > Clinical & Pharmacy
Web Content Viewer
Web Content Viewer
We’re sending health and wellness reminders to members
June 6, 2018

To help our members maintain their health, we're sending health and wellness reminders to certain members this June.  

Members with certain conditions
We will send letters to approximately 80,000 members with asthma, coronary artery disease, diabetes, and heart failure, to remind them about preventive services important to managing their health.

  • This includes members with Medicare Advantage and commercial HMO and PPO health plans.
  • The letters will tell members if they have not received critical health services (based on our claims record).
  • Eligible members over 50 will also receive reminders about the importance of mammography and colon cancer screening.
Members with Will receive information about
Asthma (ages 5+) Medication to control asthma:
  • Steroid inhaler or other controller medication
Coronary artery disease (ages 18+)
  • Statin use
Diabetes (ages 18+)
  • Statin use
  • Test to measure control of glucose over several weeks (HbA1C)
  • Eye exam
  • Urine test for kidney function
Heart failure (ages 18+) Medication to improve heart function:
  • Angiotensin converting enzyme inhibitors (ACE)
  • Angiotensin receptor blockers (ARB)
  • Beta blockers

Mammography and colon screening
Members without one of the conditions listed above, but who are eligible for routine mammography or colon screening, will get a call, email, or text telling them of the importance of these services. We will send this communication to about 200,000 members.

Members who did not have And are eligible Will receive a message about
Either a flexible sigmoidoscopy or colonoscopy or FIT-DNA or fecal occult blood test during the measure period1
  • Age: 51-75
  • Without a total colectomy
The importance of screening for colorectal cancer
A mammogram or digital breast tomosynthesis during measure period2
  • Age: 52+
  • Without a unilateral or bilateral mastectomy
The importance of screening for breast cancer
  1. Measure period for:
    • Flexible sigmoidoscopy: current measurement year or four years prior (January 1, 2014 - March 31, 2018).
    • Colonoscopy: current measurement year or nine years prior (January 1, 2009 – March 31, 2018).
    • CT-colonoscopy: current measurement year or four years prior (January 1, 2014 - March 31, 2018).
    • FIT-DNA: current measurement year or two years prior (January 1, 2016 - March 31, 2018).
    • Fecal occult blood test: current measurement year (January 1, 2018 - March 31, 2018).
  2. Measure period for mammography is October 1, 2016 - March 31, 2018.
    Note: Hospice is identified using an in-house definition and excluded from eligible population.

Please help reinforce these messages to your patients with these conditions, or who are eligible for screening services.

Resources
To view samples of the letters, log in to Provider Central, find this article in News>Clinical and Pharmacy, and open links to the adult and pediatric reminder letters.

To review the guidelines we use for our recommendations, log in and go to Clinical Resources>Clinical Programs & Information>Treatment Resources. Click on the appropriate condition and you’ll see links to nationally recognized treatment guidelines.

 

MPC_040618-1S-1-ART

Related Content

Related Content